Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Never let yourself get too hungry (triggers nausea) or too full (causes discomfort)
Ms recientemente, los investigadores han desarrollado agonistas duales, como la tirzepatida, que actan tanto sobre los receptores de GLP-1 como de GIP
Other factors, such as the drugs tendency to cause low blood sugar (hypoglycemia), interactions with other medications, and potential for severe side effects, may also result in an increased risk of the condition
Additionally, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity trial demonstrated that semaglutide consistently reduced major cardiovascular event endpoints by approximately 20% compared to placebo over an approximately 3-year follow-up period in patients with overweight or obesity and cardiovascular disease (Table 1), but without diabetes [93]
Some people may notice decreased appetite or slight dizziness